API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
98
PharmaCompass offers a list of Citalopram Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Citalopram Hydrobromide manufacturer or Citalopram Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Citalopram Hydrobromide manufacturer or Citalopram Hydrobromide supplier.
PharmaCompass also assists you with knowing the Citalopram Hydrobromide API Price utilized in the formulation of products. Citalopram Hydrobromide API Price is not always fixed or binding as the Citalopram Hydrobromide Price is obtained through a variety of data sources. The Citalopram Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Citalopram Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citalopram Hydrobromide, including repackagers and relabelers. The FDA regulates Citalopram Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citalopram Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Citalopram Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Citalopram Hydrobromide supplier is an individual or a company that provides Citalopram Hydrobromide active pharmaceutical ingredient (API) or Citalopram Hydrobromide finished formulations upon request. The Citalopram Hydrobromide suppliers may include Citalopram Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Citalopram Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Citalopram Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Citalopram Hydrobromide DMFs exist exist since differing nations have different regulations, such as Citalopram Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Citalopram Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Citalopram Hydrobromide USDMF includes data on Citalopram Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Citalopram Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF on PharmaCompass.
A Citalopram Hydrobromide CEP of the European Pharmacopoeia monograph is often referred to as a Citalopram Hydrobromide Certificate of Suitability (COS). The purpose of a Citalopram Hydrobromide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Citalopram Hydrobromide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Citalopram Hydrobromide to their clients by showing that a Citalopram Hydrobromide CEP has been issued for it. The manufacturer submits a Citalopram Hydrobromide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Citalopram Hydrobromide CEP holder for the record. Additionally, the data presented in the Citalopram Hydrobromide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Citalopram Hydrobromide DMF.
A Citalopram Hydrobromide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Citalopram Hydrobromide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Citalopram Hydrobromide suppliers with CEP (COS) on PharmaCompass.
A Citalopram Hydrobromide written confirmation (Citalopram Hydrobromide WC) is an official document issued by a regulatory agency to a Citalopram Hydrobromide manufacturer, verifying that the manufacturing facility of a Citalopram Hydrobromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Citalopram Hydrobromide APIs or Citalopram Hydrobromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Citalopram Hydrobromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Citalopram Hydrobromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Citalopram Hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Citalopram Hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Citalopram Hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Citalopram Hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Citalopram Hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Citalopram Hydrobromide suppliers with NDC on PharmaCompass.
Citalopram Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Citalopram Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Citalopram Hydrobromide GMP manufacturer or Citalopram Hydrobromide GMP API supplier for your needs.
A Citalopram Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Citalopram Hydrobromide's compliance with Citalopram Hydrobromide specifications and serves as a tool for batch-level quality control.
Citalopram Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Citalopram Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Citalopram Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Citalopram Hydrobromide EP), Citalopram Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Citalopram Hydrobromide USP).